Delivery Order SPE2DR25D1021-SPE2DR26FNN4C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,178.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on November 24, 2025, with completion expected by November 25, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $2,616.66 with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,780.03 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on November 26, 2025, with completion expected by November 28, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the broader federal medical procurement framework supporting...
- The Defense Logistics Agency awarded a delivery order valued at $6,756.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The order represents a single transaction under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,329.48 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on December 12, 2025. This is a firm fixed price, non-set-aside contract with a completion date of December 15, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a purchase of this diabetes medication, a brand-name pharmaceutical product, under a competitive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,716.43 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on August 19, 2025, with completion scheduled for August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $15,610.00 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract was executed on November 20, 2025, with an ultimate completion date of November 21, 2025. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pen injectors with a firm fixed price ceiling value of $2,644.53 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026 that supports global...
- The Defense Logistics Agency awarded a delivery order valued at $5,050.63 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on August 18, 2025, with completion targeted for August 19, 2025. The contract employs firm fixed pricing under a non-competitive delivery order structure and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,502.55 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on October 24, 2025, with completion expected by October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNN4CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,222.96 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on November 24, 2025, with completion expected by November 25, 2025. This firm fixed-price delivery order, issued without a set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement of diabetes medication to support federal medical supply needs. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains a substantial federal contract portfolio covering specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 11/23/25 |